Soluble Urokinase Plasminogen Activator Receptor is Associated with Coronary Artery Calcification and Cardiovascular Disease in Patients Undergoing Hemodialysis

• Main Authors: Wenjuan Wu (Author), Yanhai Cui (Author), Juan Hu (Author), Ruyi Liao (Author), Sijia Li (Author), Liyi Mo (Author), Lixia Xu (Author), Yuanhan Chen (Author), Zhiwen Lian (Author), Xiulan Tian (Author), Zhuo Li (Author), Ruizhao Li (Author), Li Zhang (Author), Huaban Liang (Author), Jianchao Ma (Author), Ting Lin (Author), Zhonglin Feng (Author), Wei Dong (Author), Guibao Ke (Author), Pingjiang Ge (Author), Zhiming Ye (Author), Wenjiang Wang (Author), Bing Zhang (Author), Wei Shi (Author), Xinling Liang (Author), Shuangxin Liu (Author)
• Format: Book
• Published: Karger Publishers, 2018-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background/Aims: Cardiovascular disease (CVD) is an important cause of morbidity and mortality in hemodialysis patients. Vascular calcification is thought to play an important role in causing CVD. Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker strongly predictive of cardiova...